Hints and tips:
...Colette Bowe, BSB The story of Debenhams is still being written....
...Instead I can reveal that Dugher has just emerged as one of four candidates on the shortlist for Barnsley East, where current MP Jeff Ennis is stepping down....
...This was below expectations of 66 cents a share, and disappointing to investors who are waiting for Jeff Kindler, Pfizer’s chief executive, to turn the company round....
...Under pressure from Wall Street to retool Pfizer to boost sales and profit, Jeff Kindler, chief executive, gave a frank assessment of the disruption created by its $90bn Warner-Lambert and $60bn Pharmacia...
...“The healthcare system can do the most good by getting people to take more responsibility for their own health,” says Jeff Noddle, chief executive of Supervalu, a retailer with 190,000 employees that is...
...Jeff Kindler, chief executive, overhauled management and sought to retool the group’s research and development efforts to develop more products to offset competition, patent expiries and maturing products...
...Additional reporting by Christopher Bowe in New York...
...Pfizer was interested nine months ago, as the company struggling and in transition with Jeff Kindler, its new chief executive, sought fresh ideas....
...The pressure on Pfizer to find new areas of growth have forced Jeff Kindler, its chief executive, to explore new methods....
...The drive is the most significant so far in an effort by Jeff Kindler, chief executive, to boost Pfizer’s scientific prowess and reignite sales and profit growth....
...The move is the latest in a series of measures by chief executive Jeff Kindler to correct past mistakes and try to put the struggling US pharmaceuticals company back on track....
...But Pfizer’s size has not only failed to make it a fast-growing drug company but may have left it in need of a dramatic change under Jeff Kindler, its new chief executive since July last year when the board...
...In the pharmaceuticals industry, Pfizer last year named Jeff Kindler, its general counsel, to replace Hank McKinnell as chief executive....
...Jeff is a leading advocate of change.” Mr McKinnell irritated investors recently as the share price neared eight-year lows and he struggled to guide Pfizer through tough times....
...The trial of Kenneth Lay and Jeff Skilling, Enron's former chairman and former chief executive, could begin this year....
...The trial of Ken Lay and Jeff Skilling, Enron's former chairman and former chief executive, are also up this year....
...Who could forget Jeff Skilling’s “I’m not an accountant” defence when the former chief executive of Enron denied all knowledge of the shenanigans at his company?...
International Edition